Crohn's disease: genetic susceptibility, bacteria, and innate immunity.
Van Heel
D A
DA
Wellcome Trust Centre for Human Genetics and Gastroenterology Unit, University of Oxford, OX3 7BN, Oxford, UK. david.vanheel@well.ox.ac.uk
McGovern
D P
DP
Jewell
D P
DP
D002352:Carrier Proteins; D002885:Chromosomes, Human, Pair 16; D003424:Crohn Disease / Q000235:genetics* / Q000276:immunology; D016207:Cytokines / Q000097:blood*; D016368:Frameshift Mutation; D015870:Gene Expression / Q000502:physiology; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008070:Lipopolysaccharides / Q000276:immunology*; D016328:NF-kappa B / Q000235:genetics; D053473:Nod2 Signaling Adaptor Protein; D011506:Proteins / Q000235:genetics*; D015398:Signal Transduction / Q000235:genetics
D002352:Carrier Proteins; D016207:Cytokines; D047908:Intracellular Signaling Peptides and Proteins; D008070:Lipopolysaccharides; D016328:NF-kappa B; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein; D011506:Proteins